Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Secretory IgA Induces Tolerogenic Dendritic Cells through SIGNR1 Dampening Autoimmunity in Mice.
Retinal Nerve Fiber Layer Thickness, Brain Atrophy, and Disability in Multiple Sclerosis Patients.
Regional brain atrophy and functional connectivity changes related to fatigue in multiple sclerosis.
Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits.
Current topics in therapeutic plasmapheresis.
Leber's hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery.
Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases.
Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.
Restless legs syndrome as the initial presentation of multiple sclerosis.
Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions.
Motor network efficiency and disability in multiple sclerosis.
Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations.
Molecular alterations of the blood-brain barrier under inflammatory conditions: The role of endothelial to mesenchymal transition.
Multiple sclerosis in India: An overview.
Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study.
Recognizing and overcoming potential barriers to oral medications for MS.
Multi-parametric representation of voxel-based quantitative magnetic resonance imaging.
Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
Genomic medicine and risk prediction across the disease spectrum.
Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.
CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.
Successful treatment of neuromyelitis optica spectrum disorder by early initiation of plasma exchange.
[New therapeutic options in multiple sclerosis].
Assessment of plasma brain-derived neurotrophic factor (BDNF), activity-dependent neurotrophin protein (ADNP) and vasoactive intestinal peptide (VIP) concentrations in treatment-naïve humans with multiple sclerosis.

Pages